Abstract
Various subtypes of intracerebral hamartomas, associated with seizure disorders, have long been described. We describe a cerebral hamartoma placed in the left frontal lobe, associated with drug-resistant epilepsy, composed exclusively of mature oligodendroglial cells. The patient was a 27-year-old right-handed male presenting with severe epileptic encephalopathy and symptoms of behavior dysfunction (disinhibition, rage attacks) associated with a left frontal lesion. Magnetic resonance imaging revealed a small area iso-hypointense compared to the gray matter in T1-weighted sequences not enhancing after gadolinium contrast injection in the left frontal site. On histology, a cortical lesion composed of large aggregates of oligodendroglial cells, with round central nuclei and clear perinuclear halos, was observed. Neither mitotic figures nor necrosis were present. Reactivity for Ki67 and P53 was not found. The lesion was well demarcated from the adjacent brain parenchyma and perineuronal satellitosis was not observed in the cortex. In conclusion, albeit extremely rare, recognition of oligodendroglial hamartoma and its distinction from other epileptogenic lesions as dysembryoplastic neuroepithelial tumor or above all oligodendroglioma have important therapeutic and prognostic implications.
This is a preview of subscription content, log in via an institution to check access.
References
Zentner J, Hufnagel A, Wolf HK et al (1995) Surgical treatment of temporal lobe epilepsy: clinical, radiological, and histopathological findings in 178 patients. J Neurol Neurosurg Psychiatry 158:666–673
Wolf HK, Zentner J, Hufnagel A et al (1993) Surgical pathology of chronic epileptic seizure disorders: experience with 63 specimens from extratemporal corticectomies, lobectomies and functional hemispherectomies. Acta Neuropathol 86:466–472
Babb TL, Brown WJ (1987) Pathological findings in epilepsy. In: Engel J Jr (ed) Surgical treatment of the epilepsies. Raven, New York, pp 511–539
Volk EF, Prayson RA (1997) Hamartomas in the Setting of chronic epilepsy: a clinicopathologic study of 13 cases. Hum Pathol 28:227–232
Riley K, Palmer CA, Oser AB, Paramore CG (1999) Spinal cord hamartoma: case report. Neurosurgery 44:1125–1127
Tasdemiroglu E, Nazek M, Zuccarello M (1994) Oligodendroglial hamartoma of the right temporal lobe: a case report and discussion of possible histogenesis. Clin Neuropathol 13:204–215
Engel J Jr, Van Ness PC, Rasmussen TB, Ojemann LM (1993) Outcome with respect to epileptic seizures. In: Engel J Jr (ed) Surgical treatment of the epilepsies, 2nd edn. Raven, New York, pp 609–621
Brandes AA, Tosoni A, Cavallo G et al (2006) Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study. J Clin Oncol 24:4746–4753
Engelhard HH (2002) Current diagnosis and treatment of oligodendroglioma. Neurosurg Focus 12(2):E2
Hammond RR, Dugal N, Woulfe JM, Girvin JP (2000) Malignant transformation of a dysembryoplastic neuroepithelial tumor: case report. J Neurosurg 92:722–725
Ray WZ, Blackburn SL, Casavilca-Zambrano S et al (2009) Clinicopathologic features of recurrent dysembryoplastic neuroepithelial tumor and rare malignant transformation: a report of 5 cases and review of the literature. J Neurooncol 94:283–292
Piepmeier JM (2009) Current concepts in the evaluation and management of WHO grade II gliomas. J Neurooncol 92:253–259
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marucci, G., Giulioni, M., Martinoni, M. et al. Oligodendroglial hamartoma: a potential source of misdiagnosis for oligodendroglioma. J Neurooncol 101, 325–328 (2011). https://doi.org/10.1007/s11060-010-0253-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-010-0253-2